News Releases
Renown doctor to Lead Verde Science's Huntington Disease Study
LAS VEGAS, Oct. 19, 2015 (GLOBE NEWSWIRE) -- (VRCI) Verde Science, Inc., is a leading Pharmaceutical Research and Development Company that maintains a strong collaboration with leading scientists and pharma companies to create and test pharmaceutical formulations for optimal dosage and delivery mechanisms.…
Verde Science to Sponsor/Present at the Huntington Study Group Annual Conference
LAS VEGAS, NV / ACCESSWIRE / October 12, 2015 / (OTCQB:VRCI) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabis-based prescription medicines to meet patients’ needs for a wide range of medical conditions, is pleased to announce it will…
Verde Science Announces Plan to Study Cannabis Preparation for Treatment of Huntingdon's Disease
LAS VEGAS, Oct. 9, 2015 (Globe Newswire) – Verde Science, Inc. (VRCI), a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients' needs for a wide range of medical conditions, is pleased to announce that along with…
Verde Science Appoints International Banker Manfred A. Schauer
Las Vegas NV / May 20, 2015 / (VRCI-OTCQB) Verde Science Inc., a pharmaceutical research and development company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the appointment of Manfred…
Verde Science Adds Lawyer, Bradley J. Dixon, J.D. to the Board of Directors
Las Vegas NV / May 20, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing effective treatments for contemporary health issues, with an initial focus on developing cannabinoid-based prescription medicines is pleased to announce the appointment…
Verde Science Appoints New Chief Financial Officer with Pharmaceutical Sector Experience
Las Vegas NV / May 12, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients’ needs for a wide range of medical conditions is pleased to announce the appointment of…
Verde Science Adds John M. E. Percival to the Head of Strategic Development and Member of Board of Directors
Las Vegas NV / May 4, 2015 (VRCI-OTCQB) Verde Science, Inc. a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions is pleased to announce the appointment of John M.…
Verde Science Adds Shantesh Hede, Ph.D. as Director of Product Development
Las Vegas NV / April 10, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the addition of Shantesh…
Verde Science Signs Research and Development Pact with Institute of Chemical Technology
Las Vegas NV / April 8, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the execution of a…
Verde Science Provides an Investor Update for Shareholders and Investors
Las Vegas NV / March 13, 2015 / Verde Science, Inc., (VRCI-OTCQB) a Medical Research and Development Company focused on developing effective treatments for emerging and contemporary health issues, with an initial focus on Medical Marijuana is pleased to update shareholders and investors regarding significant…